Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
04/27/2016 04/28/2016 04/29/2016 05/02/2016 05/03/2016 Date
1.06 1.05 0.97 1.07 0.98 Last
13600 7400 41777 5304 34900 Volume
-1.85% -0.94% -7.62% +10.31% -8.41% Change
Financials ( CAD)
Sales 2016 -
EBIT 2016 -12,3 M
Net income 2016 -13,4 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -11,5 M
Net income 2017 -13,4 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 0
Capitalization 38,1 M
More Financials
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
09/13Earnings Release
More about the company
Latest news on TRANSITION THERAPEUTICS IN
04/18 TRANSITION THERAPEUTICS : Provides Update on Type 2 Diabetes Drug Candidate TT40..
03/17 TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
03/01 TRANSITION THERAPEUTICS : to Present at the 36th Annual Cowen Healthcare Confere..
02/09 TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2016 Financial Results
02/05 TRANSITION THERAPEUTICS : to Hold Conference Call on Second Quarter Fiscal 2016 ..
02/01 TRANSITION THERAPEUTICS : Announces Top Line Phase 2 Clinical Study Results of D..
01/06 TRANSITION THERAPEUTICS : Announces Annual General Meeting Voting Results
2015 TRANSITION THERAPEUTICS : to Host Investor Day November 23 in New York
More news
Sector news : Biopharmaceuticals
11:33a PFIZER : Drug Companies Pony Up in Illegal Marketing Cases, But Critics Wonder i..
10:25a C4X DISCOVERY : Moves Clive Fix From Chairman To Chief Executive
09:03a MERCK AT SID : Materials for the Displays of Today and Tomorrow
More sector news : Biopharmaceuticals
News from SeekingAlpha
04/26 First patient dosed in Transition's mid-stage study of TT701 in androgen defi..
04/18 Midday Gainers/ Losers
04/18 Lilly bags development of Transition Therapeutics' diabetes candidate TT401
02/09 Transition Therapeutics' (TTHI) CEO Dr. Tony Cruz on Q2 2016 Results - Earnin..
02/09 Transition Therapeutics reports FQ2 results


Comments 
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions